Brief: SkinBioTherapeutics Posts H1 Loss Per Share Of 0.0046 GBP
26/03/2025 07:35
March 26 (Reuters) - SkinBioTherapeutics PLC SBTX.L: SKINBIOTHERAPEUTICS H1 EPS GBP -0.0046 Source text: ID:nRSZ1555Ca Further company coverage: SBTX.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Skinbiotherapeutics
See all newsBrief: SkinBioTherapeutics Appoints Rachel Parsonage As CEO & Alyson Levett As Chair On Permanent Basis
SkinBioTherapeutics - Trading Statement
Brief: SkinBioTherapeutics Appoints Anita Slater To Start As Interim CFO
SkinBioTherapeutics - Appointment of Interim CFO
SkinBioTherapeutics - Holding(s) in Company